1 |
Buregeya E, Fowler RA, Talmor DS, et al. Acute respiratory distress syndrome in the global context [J]. Glob Heart, 2014, 9(3): 289-295.
|
2 |
Angus DC, van der Poll T. Severe sepsis and septic shock [J]. N Engl J Med, 2013, 369(9): 840-851.
|
3 |
Li JT, Melton AC, Su G, et al. Unexpected role for adaptive αβTh17 cells in acute respiratory distress syndrome [J]. J Immunol, 2015, 195(1): 87-95.
|
4 |
Stockinger B, Veldhoen M, Martin B. Th17 T cells: linking innate and adaptive immunity [J]. Semin Immunol, 2007, 19(6): 353-361.
|
5 |
Risso K, Kumar G, Ticchioni M, et al. Early infectious acute respiratory distress syndrome is characterized by activation and proliferation of alveolar T-cells [J]. Eur J Clin Microbiol Infect Dis, 2015, 34(6): 1111-1118.
|
6 |
Li J, Li M, Su L, et al. Alterations of T helper lymphocyte subpopulations in sepsis, severe sepsis, and septic shock: a prospective observational study [J]. Inflammation, 2015, 38(3): 995-1002.
|
7 |
McKinley L, Logar AJ, McAllister F, et al. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia [J]. J Immunol, 2006, 177(9): 6215-6226.
|
8 |
Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis [J]. Crit Care Med, 2003, 31(7): 2068-2071.
|
9 |
Adamzik M, Broll J, Steinmann J, et al. An increased alveolar CD4+CD25+Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality [J]. Intensive Care Med, 2013, 39(10): 1743-1751.
|
10 |
Barbi J, Pardoll D, Pan F. Metabolic control of the Treg/Th17 axis [J]. Immunol Rev, 2013, 252(1): 52-77.
|
11 |
Pesce B, Soto L, Sabugo F, et al. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients [J]. Clin Exp Immunol, 2013, 171(3): 237-242.
|
12 |
Zhou L, Lopes JE, Chong MM, et al. TGF-beta-induced Foxp3 inhibits Th17 cell differentiation by antagonizing RORγ function [J]. Nature, 2008, 453(7192): 236-240.
|
13 |
Bettelli E, Korn T, Oukka M. Induction and effector functions of Th17 cells [J]. Nature, 2008, 453(7198): 1051-1057.
|
14 |
Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory Th17 cells [J]. Nature, 2007, 448(7152): 484-487.
|
15 |
Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease [J]. Clin Exp Immunol, 2007, 148(1): 32-46.
|
16 |
Jia W, Cao L, Yang S, et al. Regulatory T cells are protective in systemic inflammation [J]. PLoS One, 2013, 8(5): e64397.
|
17 |
Yu ZX, Ji MS, Yan J, et al. The ratio of Th17/Treg cells as a risk indicator in early acute respiratory distress syndrome [J]. Crit Care, 2015, 19: 82.
|
18 |
Leentjens J, Kox M, Rebecca M, et al. Reversal of immunoparalysis in humans in vivo [J]. Am J Respir Crit Care Med, 2012, 186(9): 838-845.
|
19 |
Wang D, Huang S, Yuan X, et al. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus [J]. Cell Mol Immunol, 2017, 14(5): 423-431.
|
20 |
Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial [J]. Lancet Respir Med, 2015, 3(1): 24-32.
|
21 |
Pesce B, Soto L, Sabugo F, et al. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients [J]. Clin Exp Immunol, 2013, 171(3): 237-242.
|
22 |
Tanaka T. Can IL-6 blockade rectify imbalance between Tregs and Th17 cells? [J]. Immunotherapy, 2013, 5(7): 695-697.
|